Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
Previtali SC, Gidaro T, Diaz-Manera J, et al. Rimeporide as a fi rst- in-class NHE-1 inhibitor: Results of a phase…